The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children.
We measured serum lipids and lipoproteins in 33 epileptic children who were treated with phenobarbital, valproate, and carbamazepine. High-density lipoprotein cholesterol (HDL-c) was significantly higher in the epileptic children than in two control groups: healthy nonepileptic children, and epileptic children before starting anticonvulsant therapy. Our findings indicate that anticonvulsant drugs should be added to the list of substances that affect serum HDL-c.
D000293:Adolescent; D000927:Anticonvulsants / Q000494:pharmacology*; D002220:Carbamazepine / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D002784:Cholesterol / Q000097:blood*; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood*; D010634:Phenobarbital / Q000494:pharmacology; D013268:Stimulation, Chemical; D014635:Valproic Acid / Q000494:pharmacology
D000927:Anticonvulsants; D008075:Lipoproteins, HDL; D002220:Carbamazepine; D014635:Valproic Acid; D002784:Cholesterol; D010634:Phenobarbital